Man­u­fac­tur­ing roundup: FDA, Swissmedic ink deal on phar­ma GMP; SK biotech con­tracts with Charles Riv­er for RNA ther­a­py 

The reg­u­la­to­ry agen­cies of the US and Switzer­land signed an agree­ment last week, al­low­ing them to uti­lize each oth­er’s good man­u­fac­tur­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.